S 3837 — SAVE Act of 2022
Last action — Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 117th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Securing America's Vaccines for Emergencies Act of 2022 or the SAVE Act of 2022 This bill authorizes the President to make payments to manufacturers to increase supply-chain security if doing so is important to the national defense. The President must submit a strategy to Congress that includes (1) a plan to use authorities under the Defense Production Act of 1950 to ensure the supply of medical materials essential to the national defense; and (2) plans to diversify, and address vulnerabilities in, supply chains for essential medical materials. The President must submit to Congress annual progress reports through FY2025 evaluating the implementation of the strategy.
Bill Text
- Introduced Introduced in Senate Current html March 15, 2022
Compared against current U.S. Code AI-generated reading aid — verify against the official bill.
The bill amends the Defense Production Act of 1950 to enhance the focus on securing medical materials critical to national defense and to establish a strategy for medical supply chains.
-
50 U.S.C. 4502(b)
(3) authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consideration the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;
This addition emphasizes the importance of securing medical materials within the national defense framework.
-
50 U.S.C. 4502(b)
(3)→ (4)This change renumbers the subsequent paragraphs to accommodate the new insertion.
-
50 U.S.C. 4517(a)
(including medical materials)
This addition clarifies that the President's authority also includes ensuring the availability of medical materials.
-
50 U.S.C. 4517(b)(1)
(including medical materials, such as drugs, devices, and biological products to diagnose, cure, mitigate, treat, or prevent disease, that are essential to national defense)
This elaboration specifies the type of materials included under essential materials.
-
50 U.S.C. 4511
SEC. 109. STRATEGY ON SECURING SUPPLY CHAINS FOR MEDICAL MATERIALS.
This new section requires the President to submit a strategy for securing supply chains for medical materials essential to national defense.
-
50 U.S.C. 4533
(h) Investment in Supply Chain Security.--In addition to other authorities under this title, the President may make available to an eligible entity described in paragraph (2) payments to increase the security of supply chains and supply chain activities, if the President certifies to Congress not less than 30 days before making such a payment that the payment is critical to meet national defense requirements of the United States.
This new provision allows for payments to enhance the security of supply chains crucial for national defense.
-
50 U.S.C. 4533(h)
Definitions.--In this subsection, the terms 'supply chain' and 'supply chain activities' have the meanings given those terms by the President by regulation.
This provision establishes the need for regulatory definitions related to supply chains.
-
50 U.S.C. 4533
(2) Eligible entity.--An eligible entity described in this paragraph is an entity that--
This change identifies entities eligible for payments regarding supply chain security.
Action History
-
Introduced in Senate
-
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Sponsors
- Bill Hagerty · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
- Hagerty, Bill Republican
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does S 3837 do?
- Securing America's Vaccines for Emergencies Act of 2022 or the SAVE Act of 2022 This bill authorizes the President to make payments to manufacturers to increase supply-chain security if doing so is important to the national defense. The President must submit a strategy to Congress that includes (1) a plan to use authorities under the Defense Production Act of 1950 to ensure the supply of medical materials essential to the national defense; and (2) plans to diversify, and address vulnerabilities in, supply chains for essential medical materials. The President must submit to Congress annual progress reports through FY2025 evaluating the implementation of the strategy.
- Who sponsors S 3837?
- S 3837 is sponsored by Hagerty, Bill (Republican).
- What is the current status of S 3837?
- This bill died with 117th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track S 3837?
- Track S 3837 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S 3837
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S 3837
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →